A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes

Detalles Bibliográficos
Autores principales: Slingluff, Craig L, Petroni, Gina R, Olson, Walter C, Chianese-bullock, Kimberly A, Smith, Kelly T, Smolkin, Mark E, Galeassi, Nadedja, Grosh, William, Weiss, Geoffrey, Scott, Kristy, Hornillo, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288705/
http://dx.doi.org/10.1186/2051-1426-2-S3-P60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288705/
http://dx.doi.org/10.1186/2051-1426-2-S3-P60

Ejemplares similares